Hyperbaric oxygen therapy (HBOT) supports Parkinson’s disease treatment by enhancing oxygenation, reducing oxidative stress, promoting neuroprotection and mitochondrial function, and reducing neuroinflammation. It stimulates neurogenesis, angiogenesis, and cellular repair while improving blood flow and clearing toxic metabolites. Studies suggest HBOT improves motor and non-motor symptoms, offering promise as adjunct therapy.
Read More